Products for Research Use Only
RegisterLogin

Emibetuzumab

CAT: 0804-HY-P99192-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99192-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type) . Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer[1].
CAS Number
1365287-97-3
Product Name Alternative
LY2875358
UNSPSC
12352203
Target
C-Met/HGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emibetuzumab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Emibetuzumab]
Molecular Weight
(144.56 kDa)
References & Citations
[1]Liu L, et al. LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. Clin Cancer Res. 2014 Dec 1;20 (23) :6059-70.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
E40YR1337Emibetuzumab
GTR18338390-01Emibetuzumab Antibody
E100457Emibetuzumab ELISA Kit
DHC34201Research Grade Emibetuzumab
KBI1296KRIBIOLISA™ Emibetuzumab ELISA
E55B0549Emibetuzumab (Reference antibody)
MBS3030509-01Emibetuzumab Biosimilar - Research Grade
GTR18697626-01Emibetuzumab Human Monoclonal Antibody
591825-01MET, Emibetuzumab Biosimilar (RCCP2)
ABS-177-100ugEmibetuzumab Biosimilar, Research Grade

Popular Products